Related Experiment Video
Updated: May 10, 2026

Social Defeat Stress Model for Adolescent C57BL/6 Male and Female Mice
Published on: March 15, 2024
Neurodevelopment in perinatally HIV-infected children: a concern for adolescence
Barbara Laughton1, Morna Cornell, Michael Boivin
1Children's Infectious Diseases Clinical Research Unit, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa. BL2@sun.ac.za
Insights
Children perinatally infected with HIV (PHIV+) show poorer cognitive and behavioral outcomes, especially with AIDS diagnoses. More research is urgently needed on adolescent neurodevelopment in resource-limited settings.
Area of Science:
- Neuroscience
- Pediatrics
- Infectious Diseases
Background:
- An estimated 3.4 million children globally live with HIV.
- Limited understanding exists regarding HIV and antiretroviral treatment (ART) effects on the developing brain.
- Neurodevelopmental and behavioral outcomes in perinatally HIV-infected (PHIV+) adolescents require further investigation.
Purpose of the Study:
- To review and summarize existing literature on neurodevelopmental outcomes in PHIV+ children and adolescents.
- To identify gaps in current research, particularly concerning the adolescent age group and resource-constrained settings.
Main Methods:
- Systematic literature review of studies on neurodevelopmental outcomes in PHIV+ children and adolescents.
- Synthesis of evidence on behavior, cognition, school performance, and neurological issues.
Main Results:
- PHIV+ children exhibit lower performance in general cognition, processing speed, and visual-spatial tasks compared to controls.
- Increased risk of psychiatric and mental health problems is observed in PHIV+ children.
- Children with AIDS-defining diagnoses face significantly higher risks for adverse neurodevelopmental outcomes.
Conclusions:
- There is a critical lack of research on adolescent neurodevelopment (ages 10-25) in PHIV+ individuals, especially in high-prevalence, resource-limited countries.
- Heterogeneity in infection, ART exposure, and environmental factors complicates research synthesis and generalization.
- Longitudinal studies are urgently needed to understand the neurodevelopmental trajectory in PHIV+ children and adolescents, particularly in resource-constrained settings.
Abstract:
Globally, an estimated 3.4 million children are living with HIV, yet little is known about the effects of HIV and antiretroviral treatment (ART) on the developing brain, and the neurodevelopmental and behavioural outcomes of perinatally HIV-infected (PHIV+) adolescents. We reviewed the literature on neurodevelopmental outcomes in PHIV+ children and adolescents, and summarized the current evidence on behaviour, general cognition, specific domains, hearing and language, school performance and physical disabilities due to neurological problems. Evidence suggests that PHIV+ children do not perform as well as controls on general cognitive tests, processing speed and visual-spatial tasks, and are at much higher risk for psychiatric and mental health problems. Children with AIDS-defining diagnoses are particularly at risk for poorer outcomes. A striking finding is the lack of published data specific to the adolescent age group (10-25 years), particularly from resource-constrained countries, which have the highest HIV prevalence. In addition, extreme heterogeneity in terms of timing and source of infection, and antiretroviral experience limits our ability to summarize findings of studies and generalize results to other settings. Due to the complex nature of the developing adolescent brain, environmental influences and variation in access to ART, there is an urgent need for research on the longitudinal trajectory of neurodevelopment among children and adolescents perinatally infected with HIV, especially in high burden resource-constrained settings.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Cognitive Development During Adolescence
Sexually Transmitted Infections
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Erikson's Theory on Socioemotional Development during Adolescence

